EBOO · Diagnostics — PULS Test
A simple blood draw that measures cardiac-derived proteins to estimate your near-term risk of a cardiac event — data Dr. Volpp uses to personalize your EBOO and cardiovascular protocols.
The PULS (Protein Unstable Lesion Signature) Test measures proteins released as the body responds to unstable arterial plaque — the kind that drives most heart attacks. It translates them into a personalized risk score.
Because it detects the biological activity behind cardiac events rather than waiting for a blockage, it can flag risk that standard cholesterol panels miss. Dr. Volpp uses it to decide who benefits from cardiovascular-focused EBOO protocols — and to track change over time.
A standard blood sample — no fasting, no imaging, no stress test.
Estimates the likelihood of a cardiac event within five years.
Detects plaque activity that cholesterol panels can miss.
Repeat over time to see how your protocol is working.
A quick blood draw during your visit or consultation.
Dr. Volpp reviews your score against your history and goals.
Your EBOO and cardiovascular plan is tailored to the findings.
The PULS Cardiac Test is a laboratory diagnostic and does not diagnose or treat disease on its own. It is one input into physician-guided care. Individual results vary; discuss your results with Dr. Volpp.
EBOO is offered alongside your existing care. Dr. Heather Volpp, MD reviews every patient’s health profile before treatment; a $150 phone consultation is available on request and is credited toward your first EBOO treatment. Individual results vary.
